Approval · Notice of Compliance 989 · 2000
SIMULECT: Notice of Compliance 989
Issued September 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 989
- Date
- September 1, 2000
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Immunosuppressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIMULECT | 02242815 | Marketed |
Medicinal ingredients
- BASILIXIMAB 20 MG per VIAL